Firebrick Pharma LimitedASX: FRE

Nasodine Phase 3 Clinical Trial Surpasses 80% Recruitment

May 31, 2023 at 3:22 AM UTC · Issued by Firebrick Pharma Limited

Firebrick Pharma Ltd has released a press release.

View Attachment